One possibility is that anti-tumor IgGs produce locally increase antigen presentation by DCs and/or directly promote the activity of specific subsets of CD4+ T-cells endowed with Fcγ receptors (FcγRs) [25]. The gene discussed is CD4; the disease is neoplasm.